Keegan is expected to be responsible for all financial and financing activities, corporate communications and investor relations.
Pharming CEO Sijmen de Vries said that they would like to welcome Karl to the board of management and look forward to working together on the strengthening of their relationships with current and potential shareholders and building financial stability for Pharming.
Pharming Board of Supervisory Directors chairman Jaap Blaak said that with the appointment of Karl as CFO, they consider the board of management is ready to resolve the last financial challenges.